Paul Tudor Jones Uni Qure N.V. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Uni Qure N.V. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 24,784 shares of QURE stock, worth $318,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,784
Previous 23,413
5.86%
Holding current value
$318,226
Previous $115,000
280.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding QURE
# of Institutions
171Shares Held
42.5MCall Options Held
2.61MPut Options Held
582K-
Eco R1 Capital, LLC San Francisco, CA3.4MShares$43.7 Million2.81% of portfolio
-
Vestal Point Capital, LP New York, NY3.03MShares$38.8 Million3.17% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.45MShares$31.5 Million2.18% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.18MShares$27.9 Million0.56% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$25.5 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $600M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...